Inspire Medical Systems Exceeds Analyst Estimates Ahead of Q2 2025 Earnings

Inspire Medical Systems, a prominent medical technology company, is gearing up to report its Q2 2025 earnings this Monday after the market closes. The company had a strong performance in the previous quarter, beating analysts' revenue expectations by 3.1% and reporting revenues of $201.3 million, a 22.7% increase year-over-year.

As Inspire Medical Systems heads into the upcoming earnings report, analysts are expecting the company to continue its positive momentum. They forecast a 9.5% year-over-year revenue growth, reaching $214.4 million in Q2 2025. This would mark a slowdown from the 29.6% increase recorded in the same quarter last year, but still a solid performance.

Inspire Medical Systems has a history of exceeding Wall Street's revenue estimates, missing them only once in the last two years. The company has consistently outperformed, beating top-line expectations by an average of 2.8% over the past two years.

While the broader healthcare equipment and supplies sector has faced some challenges, with share prices down 4.3% on average over the last month, Inspire Medical Systems' stock price has remained unchanged during this period. The company is heading into earnings with an average analyst price target of $210.73, compared to the current share price of $126.10.